10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,387,235 | -51.4% | 494,236 | -34.1% | 6.48% | -35.4% |
Q2 2023 | $41,908,032 | +0.1% | 750,502 | 0.0% | 10.04% | +14.0% |
Q1 2023 | $41,870,507 | +8.2% | 750,502 | -29.3% | 8.80% | -6.7% |
Q4 2022 | $38,687,692 | +27.9% | 1,061,682 | 0.0% | 9.44% | +82.8% |
Q3 2022 | $30,237,000 | -37.1% | 1,061,682 | 0.0% | 5.16% | -30.6% |
Q2 2022 | $48,041,000 | -52.7% | 1,061,682 | -20.5% | 7.43% | -22.5% |
Q1 2022 | $101,649,000 | -57.6% | 1,336,253 | -17.0% | 9.59% | +24.9% |
Q4 2021 | $239,948,000 | -8.1% | 1,610,824 | -10.2% | 7.68% | -1.5% |
Q3 2021 | $261,152,000 | -25.7% | 1,793,871 | 0.0% | 7.80% | +3.9% |
Q2 2021 | $351,276,000 | -8.6% | 1,793,871 | -15.5% | 7.51% | -20.8% |
Q1 2021 | $384,327,000 | +5.2% | 2,123,356 | -17.7% | 9.48% | -69.1% |
Q4 2020 | $365,466,000 | – | 2,580,975 | – | 30.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |